Janus Kinase Inhibitor [EPC]

3202 reported adverse events

Drugs of this class: BARICITINIB

These side effects are most commonly reported by patients taking drugs of the Janus Kinase Inhibitor [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 208
1 RHEUMATOID ARTHRITIS 116
2 OFF LABEL USE 115
3 PULMONARY EMBOLISM 109
4 NAUSEA 97
5 DEEP VEIN THROMBOSIS 95
6 HEADACHE 89
7 HERPES ZOSTER 78
8 PNEUMONIA 77
9 DIARRHOEA 72
See all common reactions for Janus Kinase Inhibitor [EPC]

Drugs of the Janus Kinase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CANDLE SYNDROME 1 1.0000
1 TOOTH DISLOCATION 6 0.2857
2 AEROCOCCUS URINAE INFECTION 1 0.1429
3 TUBULAR BREAST CARCINOMA 4 0.1379
4 INFECTIVE PERICARDIAL EFFUSION 3 0.1304
5 HEPATIC ECHINOCOCCIASIS 3 0.1071
6 TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME 4 0.1000
7 POST-ACUTE COVID-19 SYNDROME 3 0.0789
8 RADIAL NERVE COMPRESSION 2 0.0741
9 DIVERTICULITIS INTESTINAL PERFORATED 2 0.0606
See all enriched reactions for Janus Kinase Inhibitor [EPC]